# Beijing Kreate Medical Co., Ltd.

- Location (FDA's records): Beijing, CN
- FDA decisions: 3 (2026–2026): 3 510(k) clearances
- Product codes: FRO (2), QSZ (1)
- 510(k) review time since 2016: median 101 days, against 254 for FDA's reviews in the same codes and years (2 of 3 faster)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Acera Surgical, Inc.: 1 (https://510kreport.com/company/acera-surgical)
- Organogenesis, Inc.: 1 (https://510kreport.com/company/organogenesis)

## Its most-cited devices
- K251582: Redermax Antibacterial Wound Matrix (2026), cited by 1

## Recent decisions
- K261646: Redermax® Antibacterial Wound Matrix (Aug 14, 2026)
- K260020: Redermo Wound Matrix (Apr 16, 2026)
- K251582: Redermax Antibacterial Wound Matrix (Feb 2, 2026)

Source page: https://510kreport.com/company/beijing-kreate-medical